SCHEMBL29035344

SCHEMBL29035344

CC(C)(C)OC(=O)N1CC(B2OC(C)(C)C(C)(C)O2)=CC1CO[Si](c1ccccc1)(c1ccccc1)C(C)(C)C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMYD2 Q9NRG4 3/20 0.35
USP30 Q70CQ3 1/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
TSHR P16473 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
ABCB1 P08183 1/20 0.31
GPR119 Q8TDV5 1/20 0.31
RORC P51449 2/20 0.31
ROCK1 Q13464 1/20 0.31
KDM4E B2RXH2 1/20 0.31
PKM P14618 1/20 0.31
NAMPT P43490 1/20 0.31
KLK7 P49862 1/20 0.30
OPRD1 P41143 1/20 0.30
OPRK1 P41145 1/20 0.30
GAA P10253 1/20 0.30
THRB P10828 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29524125 1.00 SMYD2 (0.35) SMYD2USP30MEN1KMT2AALDH1A1
SCHEMBL30301912 1.00 SMYD2 (0.35) SMYD2USP30MEN1KMT2AALDH1A1
SCHEMBL25362860 0.90 SMYD2 (0.37) SMYD2ROCK1SMN1; SMN2
SCHEMBL27174566 0.90 SMYD2 (0.37) SMYD2ROCK1SMN1; SMN2
SCHEMBL25362863 0.90 SMYD2 (0.37) SMYD2ROCK1SMN1; SMN2
SCHEMBL23991558 0.83 USP30 (0.36) USP30MEN1KMT2A
SCHEMBL29280770 0.83 USP30 (0.36) USP30MEN1KMT2A
SCHEMBL29035259 0.80 MEN1 (0.37) SMYD2USP30MEN1KMT2AGPR119
SCHEMBL29035255 0.80 MEN1 (0.37) SMYD2USP30MEN1KMT2AGPR119
SCHEMBL13655737 0.78 RORC (0.39) USP30MEN1KMT2AABCB1GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117813298-A Imidazole indazole compounds as JAK inhibitors 施万生物制药研发IP有限责任公司 2024-04-02 CN disclosed
CN-116437913-A Pharmaceutical compounds for treating complement-mediated disorders 艾其林医药公司 2023-07-14 CN disclosed